Axon-glial interaction in the CNS: What we have learned from mouse models of Pelizaeus-Merzbacher disease

Journal of Anatomy

Volumn 219, Issue 1, 2011, Pages 33-43

  Gruenenfelder, Fredrik I ^a   Thomson, Gemma ^a   Penderis, Jacques ^a   Edgar, Julia M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Axon; Demyelination; Dysmyelination; Oligodendrocyte; Proteolipid protein

Indexed keywords

CEREBROSIDE; CHOLESTEROL; MYELIN BASIC PROTEIN; MYELIN PROTEIN; PHOSPHOLIPID; PROTEIN DM20; PROTEOLIPID PROTEIN; SULFATE; SULPHATIDE; UNCLASSIFIED DRUG;

ALLELE; AXON GLIAL INTERACTION; CELL FUNCTION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; DEMYELINATION; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; GENE EXPRESSION; GENE MUTATION; GLIA; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; KNOCKOUT MOUSE; MICROGLIA; MYELIN SHEATH; MYELINATION; NERVE FIBER; NERVE FUNCTION; NONHUMAN; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; REVIEW; SPASTIC PARAPLEGIA; SPASTIC PARAPLEGIA TYPE 2;

ANIMALS; AXONS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; MICE; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; NEUROGLIA; PELIZAEUS-MERZBACHER DISEASE;

ANIMALIA;

EID: 79958224708     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2011.01363.x     Document Type: Review

References (147)

1. Anderson TJ, Schneider A, Barrie JA, et al. (1998) Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J Comp Neurol 394, 506-519.
2. Anderson TJ, Klugmann M, Thomson CE, et al. (1999) Distinct phenotypes associated with increasing dosage of the Plp gene: implications for CMT1A due to Pmp22 gene duplication. Ann N Y Acad Sci 883, 234-246.
3. Andrews HE, White K, Thomson CE, et al. (2006) Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the shiverer mouse. J Neurosci Res 83, 1533-1539.
4. Arroyo EJ, Xu T, Grinspan J, et al. (2002) Genetic dysmyelination alters the molecular architecture of the nodal region. J Neurosci 22, 1726-1737.
5. + channel clustering. J Neurosci Res 58, 752-764.
6. Bian F, Nath R, Sobocinski G, et al. (2002) Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J Comp Neurol 446, 257-266.
7. Boison D, Stoffel W (1989) Myelin-deficient rat: a point mutation in exon III (A→C, Thr75→Pro) of the myelin proteolipid protein causes dysmyelination and oligodendrocyte death. EMBO J 8, 3295-3302.
8. Boison D, Stoffel W (1994) Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci USA 91, 11709-11713.
9. Bongarzone ER, Campagnoni CW, Kampf K, et al. (1999) Identification of a new exon in the myelin proteolipid protein gene encoding novel protein isoforms that are restricted to the somata of oligodendrocytes and neurons. J Neurosci 19, 8349-8357.
10. Bradl M, Bauer J, Inomata T, et al. (1999) Transgenic Lewis rats overexpressing the proteolipid protein gene: myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathol (Berl) 97, 595-606.
11. Brahic M, Roussarie JP (2009) Axon-myelin interactions during a viral infection of the central nervous system. PLoS Pathog 5, e1000519.
12. Brophy PJ (2003) Myelinated nerves: filling in the juxtaparanodal gap. Curr Biol 13, R956-R957.
13. Cailloux F, Gauthier-Barichard F, Mimault C, et al. (2000) Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Eur J Hum Genet 8, 837-845.
14. Campagnoni A, Skoff RP (2001) The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol 11, 74-91.
15. Cerghet M, Bessert DA, Nave KA, et al. (2001) Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways. J Neurocytol 30, 841-855.
16. De Vos K, Severin F, Van Herreweghe F, et al. (2000) Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. J Cell Biol 149, 1207-1214.
17. De Vos KJ, Sable J, Miller KE, et al. (2003) Expression of phosphatidylinositol(4, 5) bisphosphate-specific pleckstrin homology domains alters direction but not the level of axonal transport of mitochondria. Mol Biol Cell 14, 3636-3649.
18. Delarasse C, Daubas P, Mars LT, et al. (2003) Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest 112, 544-553.
19. DeLuca GC, Ebers GC, Esiri MM (2004) The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 30, 576-584.
20. Dick KJ, Eckhardt M, Paisan-Ruiz C, et al. (2010) Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat 31, E1251-E1260.
21. Duncan ID, Hammang JP, Trapp BD (1987) Abnormal compact myelin in the myelin-deficient rat: absence of proteolipid protein correlates with a defect in the intraperiod line. Proc Natl Acad Sci USA 84, 6287-6291.
22. Duncan ID, Hammang JP, Goda S, et al. (1989) Myelination in the jimpy mouse in the absence of proteolipid protein. Glia 2, 148-154.
23. Dutta R, Trapp BD (2010) Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 93, 1-12.
24. Edgar JM, Nave KA (2009) The role of CNS glia in preserving axon function. Curr Opin Neurobiol 19, 498-504.
25. Edgar JM, Anderson TJ, Dickinson PJ, et al. (2002) Survival of, and competition between, oligodendrocytes expressing different alleles of the Plp gene. J Cell Biol 158, 719-729.
26. Edgar JM, McLaughlin M, Barrie JA, et al. (2004a) Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene. Acta Neuropathol (Berl) 107, 331-335.
27. Edgar JM, McLaughlin M, Yool D, et al. (2004b) Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166, 121-131.
28. Edgar JM, McLaughlin M, Werner HB, et al. (2009) Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia 57, 1815-1824.
29. Edgar JM, McCulloch MC, Montague P, et al. (2010) Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol Med 2, 42-50.
30. Feng GP, Mellor RH, Bernstein M, et al. (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41-51.
31. Franklin RJ, ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9, 839-855.
32. Friede RL, Samorajski T (1970) Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat Rec 167, 379-388.
33. Fulton D, Paez PM, Campagnoni AT (2010) The multiple roles of myelin protein genes during the development of the oligodendrocyte. ASN Neuro 2, e00027.
34. Garbern JY (2007) Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis. Cell Mol Life Sci 64, 50-65.
35. Garbern J, Hobson G (2002) Prenatal diagnosis of Pelizaeus-Merzbacher disease. Prenat Diagn 22, 1033-1035.
36. Garbern J, Yool DA, Moore GJ, et al. (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125, 551-561.
37. Garthwaite G, Batchelor AM, Goodwin DA, et al. (2005) Pathological implications of iNOS expression in central white matter: an ex vivo study of optic nerves from rats with experimental allergic encephalomyelitis. Eur J Neurosci 21, 2127-2135.
38. Gencic S, Abuelo D, Ambler M, et al. (1989) Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein. Am J Hum Genet 45, 435-442.
39. Gow A, Wrabetz L (2009) CHOP and the endoplasmic reticulum stress response in myelinating glia. Curr Opin Neurobiol 19, 505-510.
40. Griffiths IR, Klugmann M, Anderson TJ, et al. (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280, 1610-1613.
41. Harrington EP, Zhao C, Fancy SP, et al. (2010) Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Ann Neurol 68, 703-716.
42. Hess A, Young JZ (1952) The nodes of Ranvier. Proc R Soc Lond B Biol Sci 140, 301-320.
43. Hildebrand C, Remahl S, Persson H, et al. (1993) Myelinated nerve fibres in the CNS. Prog Neurobiol 40, 319-384.
44. Hirano A, Llena JF (1995) Morphology of central nervous system axons. In The Axon (eds Waxman SG, Kocsis JD, Stys PK), pp. 49-67. New York: Oxford University Press.
45. Hirokawa N, Sato-Yoshitake R, Yoshida T, et al. (1990) Brain dynein (MAP1C) localizes on both anterogradely and retrogradely transported membranous organelles in vivo. J Cell Biol 111, 1027-1037.
46. Hodes ME, Blank CA, Pratt VM, et al. (1997) Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus-Merzbacher disease. Am J Med Genet 69, 121-125.
47. Hogan V, White K, Edgar J, et al. (2009) Increase in mitochondrial density within axons and supporting cells in response to demyelination in the Plp1 mouse model. J Neurosci Res 87, 452-459.
48. Howell OW, Rundle JL, Garg A, et al. (2010) Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol 69, 1017-1033.
49. Hudson LD, Puckett C, Berndt J, et al. (1989) Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. Proc Natl Acad Sci USA 86, 8128-8131.
50. Hudson LD, Garbern JY, Kamholz JA (2004) Pelizaeus-Merzbacher disease. In Myelin Biology and Disorders (eds Lazzarini RA, Griffin JW, Lassmann H, Nave K-A, Miller RH, Trapp BD), pp. 867-885. Amsterdam: Elsevier.
51. Ikenaka K, Kagawa T, Mikoshiba K (1992) Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and in non-glial cells. J Neurochem 58, 2248-2253.
52. Inoue Y, Kagawa T, Matsumura Y, et al. (1996) Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage. Neurosci Res 25, 161-172.
53. Ip CW, Kroner A, Bendszus M, et al. (2006) Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J Neurosci 26, 8206-8216.
54. Ip CW, Kroner A, Crocker PR, et al. (2007) Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiol Dis 25, 105-111.
55. + macrophage-like cells in the CNS of PLP-overexpressing mice: low influx of haematogenous macrophages and unchanged blood-brain-barrier in the optic nerve. Mol Cell Neurosci 38, 489-494.
56. Jahn O, Tenzer S, Werner HB (2009) Myelin proteomics: molecular anatomy of an insulating sheath. Mol Neurobiol 40, 55-72.
57. Jurevics H, Hostettler J, Sammond DW, et al. (2003) Normal metabolism but different physical properties of myelin from mice deficient in proteolipid protein. J Neurosci Res 71, 826-834.
58. Kagawa T, Ikenaka K, Inoue Y, et al. (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13, 427-442.
59. Kaplan MR, Meyer-Franke A, Lamber S, et al. (1997) Induction of sodium channel clustering by oligodendrocytes. Nature 386, 724-728.
60. Karim SA, Barrie JA, McCulloch MC, et al. (2007) PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease. Glia 55, 341-351.
61. Karim SA, Barrie JA, McCulloch MC, et al. (2010) PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease. Glia 58, 1727-1738.
62. Kassmann CM, Lappe-Siefke C, Baes M, et al. (2007) Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 39, 969-976.
63. Kidd GJ, Hauer PE, Trapp BD (1990) Axons modulate myelin protein messenger RNA levels during central nervous system myelination in vivo. J Neurosci Res 26, 409-418.
64. Kiryu-Seo S, Ohno N, Kidd GJ, et al. (2010) Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci 30, 6658-6666.
65. Klugmann M, Schwab MH, Pühlhofer A, et al. (1997) Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18, 59-70.
66. Koeberle PD, Ball AK (1999) Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells. Exp Neurol 158, 366-381.
67. Koo EH, Sisodia SS, Archer DR, et al. (1990) Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci U S A 87, 1561-1565.
68. Kroner A, Ip CW, Thalhammer J, et al. (2010) Ectopic T-cell specificity and absence of perforin and granzyme B alleviate neural damage in oligodendrocyte mutant mice. Am J Pathol 176, 549-555.
69. Kronquist KE, Crandall BF, Macklin WB, et al. (1987) Expression of myelin proteins in the developing human spinal cord: cloning and sequencing of human proteolipid protein cDNA. J Neurosci Res 18, 395-401.
70. LaMantia AS, Rakic P (1990) Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey. J Comp Neurol 291, 520-537.
71. Lappe-Siefke C, Goebbels S, Gravel M, et al. (2003) Disruption of the CNP gene uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33, 366-374.
72. Lassmann H (2010) What drives disease in multiple sclerosis: inflammation or neurodegeneration? Clin Exp Neuroimmunol 1, 2-11.
73. LeVine SM, Wong D, Macklin WB (1990) Developmental expression of proteolipid protein and DM-20 mRNAs and proteins in the rat brain. Dev Neurosci 12, 235-250.
74. Li W, Zhang B, Tang J, et al. (2007) Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating α-tubulin. J Neurosci 27, 2606-2616.
75. Loers G, Aboul-Enein F, Bartsch U, et al. (2004) Comparison of myelin, axon, lipid, and immunopathology in the central nervous system of differentially myelin-compromised mutant mice: a morphological and biochemical study. Mol Cell Neurosci 27, 175-189.
76. Macklin WB, Campagnoni AT, Deininger PL, et al. (1987) Structure and expression of the mouse proteolipid protein gene. J Neurosci Res 18, 383-394.
77. McLaughlin M, Hunter DJB, Thomson CE, et al. (2002) Evidence for possible interactions between PLP and DM20 within the myelin sheath. Glia 39, 31-36.
78. McLaughlin M, Barrie JA, Karim SA, et al. (2006) Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation. Glia 53, 715-722.
79. Medana I, Martinic MA, Wekerle H, et al. (2001) Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol 159, 809-815.
80. Middlemas A, Delcroix JD, Sayers NM, et al. (2003) Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3. Brain 126, 1671-1682.
81. Milner RJ, Lai C, Nave K-A, et al. (1985) Nucleotide sequence of two mRNAs for rat brain myelin proteolipid protein. Cell 42, 931-939.
82. Mobius W, Patzig J, Nave KA, et al. (2008) Phylogeny of proteolipid proteins: divergence, constraints, and the evolution of novel functions in myelination and neuroprotection. Neuron Glia Biol 4, 111-127.
83. Morell P, Norton WT (1980) Myelin. Sci Am 242, 74-89.
84. Morfini G, Szebenyi G, Elluru R, et al. (2002) Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 21, 281-293.
85. Morfini GA, Burns M, Binder LI, et al. (2009) Axonal transport defects in neurodegenerative diseases. J Neurosci 29, 12776-12786.
86. Murray JA, Blakemore WF (1980) The relationship between internodal length and fibre diameter in the spinal cord of the cat. J Neurol Sci 45, 29-41.
87. Mutsaers SE, Carroll WM (1998) Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve. Acta Neuropathol (Berl) 96, 139-143.
88. Nadon NL, Duncan ID, Hudson LD (1990) A point mutation in the proteolipid protein gene of the 'shaking pup' interrupts oligodendrocyte development. Development 110, 529-537.
89. Nave KA (2010) Myelination and the trophic support of long axons. Nat Rev Neurosci 11, 275-283.
90. Nave K-A, Boespflug-Tanguy O (1996) X-linked developmental defects in myelination: from mouse mutants to human genetic diseases. The Neuroscientist 2, 33-43.
91. Nave K-A, Griffiths IR (2004) Models of Pelizaeus-Merzbacher disease. In Myelin Biology and Disorders (eds Lazzarini RA, Griffin JW, Lassmann H, Nave K-A, Miller RH, Trapp BD), pp. 1125-1142. Amsterdam: Elsevier.
92. Nave KA, Trapp BD (2008) Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31, 535-561.
93. Nave K-A, Lai C, Bloom FE, et al. (1986) Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc Natl Acad Sci USA 83, 9264-9268.
94. Nave K-A, Lai C, Bloom FE, et al. (1987) Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci USA 84, 5665-5669.
95. Nguyen T, Mehta NR, Conant K, et al. (2009) Axonal protective effects of the myelin-associated glycoprotein. J Neurosci 29, 630-637.
96. Novotny GE (1984) Formation of cytoplasm-containing vesicles from double-walled coated invaginations containing oligodendrocytic cytoplasm at the axon-myelin sheath interface in adult mammalian central nervous system. Acta Anat (Basel) 119, 106-112.
97. Osaka H, Kawanishi C, Inoue K, et al. (1995) Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males. Biochem Biophys Res Commun 215, 835-841.
98. Palin K, Cunningham C, Forse P, et al. (2008) Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration. Neurobiol Dis 30, 19-29.
99. Pan B, Fromholt SE, Hess EJ, et al. (2005) Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol 195, 208-217.
100. Patrick GN, Zukerberg L, Nikolic M, et al. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
101. Popot J-L, Dinh DP, Dautigny A (1991) Major myelin proteolipid: the 4-α-helix topology. J Membr Biol 120, 233-246.
102. Ransom BR, Butt AM, Black JA (1991) Ultrastructural identification of HRP-injected oligodendrocytes in the intact rat optic nerve. Glia 4, 37-45.
103. Rasband MN, Peles E, Trimmer JS, et al. (1999) Dependence of nodal sodium channel clustering on paranodal axoglial contact in the developing CNS. J Neurosci 19, 7516-7528.
104. Rasband MN, Tayler J, Kaga Y, et al. (2005) CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 50, 86-90.
105. Readhead C, Schneider A, Griffiths IR, et al. (1994) Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12, 583-595.
106. Reid E, Kloos M, Ashley-Koch A, et al. (2002) A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71, 1189-1194.
107. Rosenbluth J (2009) Multiple functions of the paranodal junction of myelinated nerve fibers. J Neurosci Res 15, 3250-3258.
108. Rosenbluth J, Nave KA, Mierzwa A, et al. (2006) Subtle myelin defects in PLP-null mice. Glia 54, 172-182.
109. Rushton WA (1951) A theory of the effects of fibre size in medullated nerve. J Physiol 115, 101-122.
110. Sarret C, Combes P, Micheau P, et al. (2010) Novel neuronal proteolipid protein isoforms encoded by the human myelin proteolipid protein 1 gene. Neuroscience 166, 522-538.
111. Saugier-Veber P, Munnich A, Bonneau D, et al. (1994) X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6, 257-262.
112. Schindler P, Luu B, Sorokine O, et al. (1990) Developmental study of proteolipids in bovine brain: a novel proteolipid and DM-20 appear before proteolipid protein (PLP) during myelination. J Neurochem 55, 2079-2085.
113. Schneider A, Montague P, Griffiths IR, et al. (1992) Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358, 758-761.
114. Simons R, Alon N, Riordan JR (1987) Human myelin DM-20 proteolipid protein deletion defined by cDNA sequence. Biochem Biophys Res Commun 146, 666-671.
115. Simons M, Krämer EM, Macchi P, et al. (2002) Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol 157, 327-336.
116. Song J, Goetz BD, Kirvell SL, et al. (2001) Selective myelin defects in the anterior medullary velum of the taiep mutant rat. Glia 33, 1-11.
117. Southwood C, Gow A (2001) Molecular pathways of oligodendrocyte apoptosis revealed by mutations in the proteolipid protein gene. Microsc Res Tech 52, 700-708.
118. Spencer PS, Thomas PK (1974) Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseased axons. J Neurocytol 3, 763-783.
119. Spencer PS, Sabri MI, Schaumburg HH, et al. (1979) Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann Neurol 5, 501-507.
120. Spörkel O, Uschkureit T, Büssow H, et al. (2002) Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development. Glia 37, 19-30.
121. Stagi M, Dittrich PS, Frank N, et al. (2005) Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide. J Neurosci 25, 352-362.
122. Stagi M, Gorlovoy P, Larionov S, et al. (2006) Unloading kinesin transported cargoes from the tubulin track via the inflammatory c-Jun N-terminal kinase pathway. FASEB J 20, 2573-2575.
123. Stecca B, Southwood CM, Gragerov A, et al. (2000) The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. J Neurosci 20, 4002-4010.
124. Susuki K, Rasband MN (2008) Molecular mechanisms of node of Ranvier formation. Curr Opin Cell Biol 20, 616-623.
125. Takeuchi H, Mizuno T, Zhang G, et al. (2005) Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J Biol Chem 280, 10444-10454.
126. Tatar CL, Appikatla S, Bessert DA, et al. (2010) Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain. ASN Neuro 2, e00043. DOI: 10.1042/AN20100016.
127. Thaxton C, Bhat MA (2009) Myelination and regional domain differentiation of the axon. Results Probl Cell Differ 48, 1-28.
128. Timsit SG, Bally-Cuif L, Colman DR, et al. (1992) DM-20 mRNA is expressed during the embryonic development of the nervous system of the mouse. J Neurochem 58, 1172-1175.
129. Trapp BD, Nishiyama A, Cheng D, et al. (1997) Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 137, 459-468.
130. Trinczek B, Ebneth A, Mandelkow EM, et al. (1999) Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J Cell Sci 112(Pt 14), 2355-2367.
131. Trofatter JA, Dlouhy SR, DeMyer W, et al. (1989) Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant. Proc Natl Acad Sci USA 86, 9427-9430.
132. Wang E, Dimova N, Sperle K, et al. (2008) Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability. Exp Neurol 214, 322-330.
133. Weimbs T, Stoffel W (1992) Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 31, 12289-12296.
134. Werner HB, Kuhlmann K, Shen S, et al. (2007) Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci 27, 7717-7730.
135. Wilkins A, Kondo Y, Song J, et al. (2010) Slowly progressive axonal degeneration in a rat model of chronic, nonimmune-mediated demyelination. J Neuropathol Exp Neurol 69, 1256-1269.
136. Witt A, Brady ST (2000) Unwrapping new layers of complexity in axon/glial relationships. Glia 29, 112-117.
137. Wolman M (1968) Histochemistry of demyelination and myelination. J Histochem Cytochem 16, 803-807.
138. Woodward KJ (2008) The molecular and cellular defects underlying Pelizaeus-Merzbacher disease. Expert Rev Mol Med 10, e14.
139. Xu M, Gu Y, Barry J, et al. (2010) Kinesin I transports tetramerized Kv3 channels through the axon initial segment via direct binding. J Neurosci 30, 15987-16001.
140. Yin XH, Crawford TO, Griffin JW, et al. (1998) Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18, 1953-1962.
141. Yin X, Baek RC, Kirschner DA, et al. (2006) Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol 172, 469-478.
142. Yin X, Kidd GJ, Nave KA, et al. (2008) P0 protein is required for and can induce formation of Schmidt-Lantermann incisures in myelin internodes. J Neurosci 28, 7068-7073.
143. Yool DA, Edgar JM, Montague P, et al. (2000) The proteolipid protein gene and myelin disorders in man and animal models. Hum Mol Genet 9, 987-992.
144. Yool DA, Klugmann M, McLaughlin M, et al. (2001) Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons. J Neurosci Res 63, 151-164.
145. Yool D, Klugmann M, Barrie JA, et al. (2002a) Observations on the structure of myelin lacking the major proteolipid protein. Neuropathol Appl Neurobiol 28, 75-78.
146. Yool D, Montague P, McLaughlin M, et al. (2002b) Phenotypic analysis of mice deficient in the major myelin protein MOBP, and evidence for a novel Mobp isoform. Glia 39, 256-267.
147. Zoller I, Meixner M, Hartmann D, et al. (2008) Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. J Neurosci 28, 9741-9754.